Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ranjbar, Sheyda"'
Autor:
Hargrove, Derek, Ranjbar, Sheyda, Darji, Mittal, Nam, Sangho, Dawson, Robert J, Katugampola, Sumudu, Lin, Xinhao, Brown, Amy, Carrasco-Rojas, Natalia, Goodwin, Cameron, Howell, Roger W., Bolch, Wesley E., Jay, Michael, Salner, Andrew, Lu, Xiuling
Publikováno v:
In International Journal of Pharmaceutics 25 January 2025 669
Publikováno v:
In Advanced Drug Delivery Reviews October 2023 201
Autor:
Babavalian, Anahita, Tekie, Farnaz Sadat Mirzazadeh, Ayazi, Hossein, Ranjbar, Sheyda, Varshochian, Reyhaneh, Rad-Malelkshahi, Mazda, Akhavan, Omid, Dinarvand, Rassoul
Publikováno v:
In Journal of Drug Delivery Science and Technology July 2022 73
Publikováno v:
In Journal of Drug Delivery Science and Technology January 2022 67
Autor:
Sepand, Mohammad Reza, Ranjbar, Sheyda, Kempson, Ivan M, Akbariani, Mostafa, Muganda, Willis Collins Akeyo, Müller, Mareike, Ghahremani, Mohammad Hossein, Raoufi, Mohammad
Publikováno v:
In Nanomedicine: Nanotechnology, Biology, and Medicine October 2020 29
Autor:
Ranjbar, Sheyda1, Seyednejad, Seyed Afshin2, Azimi, Haniye2, Rezaeizadeh, Hossein3, Rahimi, Roja4,5 rojarahimi@gmail.com
Publikováno v:
Nutrition & Cancer. 2019, Vol. 71 Issue 1, p1-12. 12p. 1 Diagram, 5 Charts.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Drug Delivery Science and Technology; 20210101, Issue: Preprints
Autor:
Mohammad Raoufi, Mostafa Akbariani, Mohammad Reza Sepand, Mareike Müller, Mohammad Hossein Ghahremani, Sheyda Ranjbar, Ivan M. Kempson, Willis Collins Akeyo Muganda
Publikováno v:
Nanomedicine: Nanotechnology, Biology and Medicine. 29:102243
Many tumors develop resistance to most of the apoptosis-based cancer therapies. In this sense targeting non-apoptotic forms of cell death including necroptosis, autophagy and ferroptosis may have therapeutic benefits in apoptosis-defective cancer cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6094f6501ba7d0fb16605bd78339eda
https://doi.org/10.1016/j.nano.2020.102243
https://doi.org/10.1016/j.nano.2020.102243
Autor:
Hargrove D; Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA., Ranjbar S; Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA., Darji M; Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA., Nam S; Rhode Island Nuclear Science Center, RI, USA., Dawson RJ; J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Orlando, FL, USA., Katugampola S; Department of Radiology, Rutgers New Jersey Medical School, NJ, USA., Lin X; Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA., Brown A; Hartford Healthcare Medical Group, Hartford, CT, USA., Carrasco-Rojas N; J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Orlando, FL, USA., Goodwin C; Rhode Island Nuclear Science Center, RI, USA., Howell RW; Department of Radiology, Rutgers New Jersey Medical School, NJ, USA., Bolch WE; J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Orlando, FL, USA., Jay M; Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA; Nami Therapeutics Corporation. Storrs, CT, USA., Salner A; Hartford Healthcare Medical Group, Hartford, CT, USA., Lu X; Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA. Electronic address: xiuling.lu@uconn.edu.
Publikováno v:
International journal of pharmaceutics [Int J Pharm] 2024 Dec 09, pp. 125071. Date of Electronic Publication: 2024 Dec 09.